• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

307
67
51
49
45

COUNTRY

28
12
11
11
11

PRICE

306
486
1,099
1,380

PUBLISHED

54
148
394
1,380

PRODUCT TYPE

1,205
91
51
17
16

Infectious Diseases

Antibiotics, antifungals, antivirals and other infectious disease pharmaceuticals account for a multibillion sector. The battle against contagious diseases takes places in a highly changeable environment, with a wealth of commercial opportunities arising from quickly emerging threats (e.g. avian flu) and the infectious disease and vaccination policies of national governments and international healthcare organisations. Keep track of the latest industry news and activity with the publications listed under Research and Markets’ Infectious Diseases category.

Our reports, books, and subscriptions will allow you to explore licensing, patents, forecasts, market trends, clinical trials, and drug pipelines. Leading players featured in our publications include Pfizer, Roche, Novartis, AstraZeneca, Sanofi, Johnson & Johnson, Merck, Abbott, GlaxoSmithKline, Lilly, and more.

For publications about Infectious Disease Testing please visit the relevant category under Healthcare and Medical Devices. Show Less
Read more

PRODUCT TITLE

Toxoplasmosis Global Clinical Trials Review, H2, 2014

Toxoplasmosis Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Toxoplasmosis Global Clinical Trials Review, H2, 2014" provides data on the Toxoplasmosis clinical trial scenario....

December 2014
FROM

Marburg Hemorrhagic Fever - Pipeline Review, H2 2014

Marburg Hemorrhagic Fever - Pipeline Review, H2 2014 Summary This, ‘Marburg Hemorrhagic Fever - Pipeline Review, H2 2014’, provides an overview of the Marburg Hemorrhagic Fever’s therapeutic pipeline. This...

December 2014
FROM

Community Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014

Community Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014 Summary This, ‘Community Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections...

December 2014
FROM

Resistant Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014

Resistant Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014 Summary This, ‘Resistant Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2014’, provides an overview of the Resistant...

December 2014
FROM

Pneumocystis Infection - Pipeline Review, H2 2014

Pneumocystis Infection - Pipeline Review, H2 2014 Summary This, ‘Pneumocystis Infection - Pipeline Review, H2 2014’, provides an overview of the Pneumocystis Infection’s therapeutic pipeline. This...

December 2014
FROM

Oropharyngeal Candidiasis - Pipeline Review, H2 2014

Oropharyngeal Candidiasis - Pipeline Review, H2 2014 Summary This, ‘Oropharyngeal Candidiasis - Pipeline Review, H2 2014’, provides an overview of the Oropharyngeal Candidiasis’s therapeutic pipeline. This...

December 2014
FROM

Arenavirus Infection Lassa Fever - Pipeline Review, H2 2014

Arenavirus Infection Lassa Fever - Pipeline Review, H2 2014 Summary This, ‘Arenavirus Infection Lassa Fever - Pipeline Review, H2 2014’, provides an overview of the Arenavirus Infection Lassa Fever’s...

December 2014
FROM

Schistosomiasis - Pipeline Review, H2 2014

Schistosomiasis - Pipeline Review, H2 2014 Summary This, ‘Schistosomiasis - Pipeline Review, H2 2014’, provides an overview of the Schistosomiasis’s therapeutic pipeline. This report provides comprehensive...

December 2014
FROM

Kaposi's Sarcoma - Pipeline Review, H2 2014

Kaposi's Sarcoma - Pipeline Review, H2 2014 Summary This, ‘Kaposi's Sarcoma - Pipeline Review, H2 2014’, provides an overview of the Kaposi's Sarcoma’s therapeutic pipeline. This report provides...

December 2014
FROM

Cryptosporidiosis - Pipeline Review, H2 2014

Cryptosporidiosis - Pipeline Review, H2 2014 Summary This, ‘Cryptosporidiosis - Pipeline Review, H2 2014’, provides an overview of the Cryptosporidiosis’s therapeutic pipeline. This report provides...

December 2014
FROM

Burkholderia Pseudomallei Infections - Pipeline Review, H2 2014

Burkholderia Pseudomallei Infections - Pipeline Review, H2 2014 Summary This, ‘Burkholderia Pseudomallei Infections - Pipeline Review, H2 2014’, provides an overview of the Burkholderia Pseudomallei...

December 2014
FROM

Complicated Skin And Skin Structure Infections (cSSSI) - Pipeline Review, H2 2014

Complicated Skin And Skin Structure Infections (cSSSI) - Pipeline Review, H2 2014 Summary This, ‘Complicated Skin And Skin Structure Infections (cSSSI) - Pipeline Review, H2 2014’, provides an overview...

December 2014
FROM

Chlamydia Trachomatis Infections - Pipeline Review, H2 2014

Chlamydia Trachomatis Infections - Pipeline Review, H2 2014 Summary This, ‘Chlamydia Trachomatis Infections - Pipeline Review, H2 2014’, provides an overview of the Chlamydia Trachomatis Infections’s...

December 2014
FROM

Septicaemia - Pipeline Review, H2 2014

Septicaemia - Pipeline Review, H2 2014 Summary This, ‘Septicaemia - Pipeline Review, H2 2014’, provides an overview of the Septicaemia’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM

Hepatitis D - Pipeline Review, H2 2014

Hepatitis D - Pipeline Review, H2 2014 Summary This, ‘Hepatitis D - Pipeline Review, H2 2014’, provides an overview of the Hepatitis D’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM

Francisella Tularensis Infections - Pipeline Review, H2 2014

Francisella Tularensis Infections - Pipeline Review, H2 2014 Summary This, ‘Francisella Tularensis Infections - Pipeline Review, H2 2014’, provides an overview of the Francisella Tularensis Infections’s...

December 2014
FROM

Bacterial Vaginosis - Pipeline Review, H2 2014

Bacterial Vaginosis - Pipeline Review, H2 2014 Summary This, ‘Bacterial Vaginosis - Pipeline Review, H2 2014’, provides an overview of the Bacterial Vaginosis’s therapeutic pipeline. This report...

December 2014
FROM

Burkholderia Infections - Pipeline Review, H2 2014

Burkholderia Infections - Pipeline Review, H2 2014 Summary This, ‘Burkholderia Infections - Pipeline Review, H2 2014’, provides an overview of the Burkholderia Infections’s therapeutic pipeline. This...

December 2014
FROM

Rubella - Pipeline Review, H2 2014

Rubella - Pipeline Review, H2 2014 Summary This, ‘Rubella - Pipeline Review, H2 2014’, provides an overview of the Rubella’s therapeutic pipeline. This report provides comprehensive information on...

December 2014
FROM

Hospital Acquired Pneumonia (HAP) Global Clinical Trials Review, H2, 2014

Hospital Acquired Pneumonia (HAP) Global Clinical Trials Review, H2, 2014 Summary Our clinical trial report, “Hospital Acquired Pneumonia (HAP) Global Clinical Trials Review, H2, 2014" provides data...

December 2014
FROM
Loading Indicator

Our Clients

Genentech, Inc. GlaxoSmithKline PLC Maquet Getinge Group Emergent BioSolutions, Inc. Aicuris GmbH & Co.KG Merck & Co., Inc.